Targeting estrogen and HER2 receptors through PET imaging

FDG-PET is currently one of the only molecular imaging techniques used in oncology — but that may soon change.

New PET probes being tested have shown promise, especially in breast cancer clinical trials. Experts at the Abramson Cancer Center and University of Pennsylvania believe that they can make it easier to diagnose, monitor and treat patients. Read more.